PubMed Health⌕ Search

PubMed · 15672995

[Diabetes and gestation].

Abstract

Diabetes during pregnancy is an extra burden for both the mother and the child. Pregnancy is diabetogenic and it has a tendency to aggravate preexisting diabetes or to make manifest a latent form of diabetes which causes grave consequences in the health of the mother and the fetus. The influence of diabetes during pregnancy is unfavorable. Diabetes causes frequent complications for the pregnant woman; diabetes leads to a more rapid growth of a fetus and the placenta becomes larger and hypertropic. Therefore it is so important to make an early detection of diabetes during pregnancy and to carry out a good control of it. From the Primary Care and Treatment Center both in the nursing office and by the midwife, this control is carried out along three directions: nutritional treatment, exercise, and a control of post-prandial glycemias. On behalf of the midwife, the midwife follows a protocol to detect complications derived from obstetrics. After birth, the midwife will continue making a follow-up on the woman who has given birth until she finalizes nursing her child.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Consuelo Fernández Yagüe. 2004. [Diabetes and gestation].. https://pubmed.ncbi.nlm.nih.gov/15672995/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.

The purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence but not completely suppressed the occurrence of insulin allergy manifestations. Advances in technologies concerning the mode of delivery of insulin, i.e. continuous subcutaneous insulin infusion (CSII), and the use of insulin analogues, resulting from the alteration in the amino acid sequence of the native insulin molecule, may influence the immunogenicity and antigenicity of native insulin. Instead of increasing allergy reactions, CSII has been reported to represent a successful alternative treatment in diabetic patients presenting local or generalized allergy to insulin or other components (zinc, protamine) of conventional treatment. Most recent reports concern CSII-treated patients using short-acting insulin analogues (essentially insulin lispro), although the precise role of these insulin analogues remains unclear as allergy to them has also been described. Finally, data on antigenicity and immunogenicity of long-acting insulin analogues (glargine, detemir), which may mimic the basal insulin delivery with CSII, remain scarce at present.

Diabetes Mellitus↗

Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.

Insulin deficiency is known to be associated with a state of increased muscle protein breakdown; this process is mediated by the ubiquitin-proteasome pathway. Convincing in vitro data are further supported by extensive studies in humans with insulin deprivation and are further substantiated by reversal of muscle protein breakdown with insulin treatment. In patients with end-stage renal disease (ESRD) and diabetes mellitus (DM), muscle protein breakdown is enhanced in both acute and chronic conditions. Recent data also point to the potential protein catabolic effects of insulin resistance combined with insulin deficiency. Because ESRD is associated with a state of insulin resistance, uremic muscle wasting may also be mediated by this pathway.

Diabetes Mellitus↗